Brogan P A, Shah V, Klein N, Dillon M J
Institute of Child Health, London, UK.
Arthritis Rheum. 2004 Feb;50(2):589-97. doi: 10.1002/art.20021.
To investigate the potential for endothelial cells to operate as superantigen-presenting cells for T cells and the potential for such an interaction to cause endothelial cell activation and injury.
Class II major histocompatibility complex (MHC)-positive human umbilical vein endothelial cells (HUVECs) were cocultured for 4 hours with purified T cells and the superantigens staphylococcal enterotoxin B (SEB) or toxic shock syndrome toxin 1 (TSST-1). After staining with fluorescence-conjugated monoclonal antibodies, flow cytometric analysis was performed on the HUVECs and T cells to examine V(beta)-restricted T cell adherence to the endothelial cell monolayer, V(beta)-restricted T cell activation (CD69 up-regulation), surface expression of endothelial cell activation markers, and generation of endothelial microparticles (EMPs).
Coculture of purified T cells with class II MHC-positive HUVECs and either TSST-1 or SEB resulted in V(beta)-restricted CD69 up-regulation by CD4 and CD8 cells (V(beta)2 activation for TSST-1; V(beta)3, V(beta)5.1, and V(beta)12 activation for SEB). Additionally, there was CD4 and CD8 T cell V(beta)-restricted adherence to the HUVEC monolayer at 4 hours. Expression of intercellular adhesion molecule 1, E-selectin, and vascular cell adhesion molecule 1 was up-regulated on the class II MHC-positive HUVECs following exposure to superantigen in the presence of T cells, and there was increased EMP release from activated HUVECs, which occurred earlier and was of greater magnitude than that observed in response to tumor necrosis factor alpha.
Class II MHC-positive endothelial cells operate as competent superantigen-presenting cells for CD4 and CD8 lymphocytes in vitro. Dual signaling between endothelial cells and T cells results in V(beta)-restricted activation and adherence to endothelial monolayers and endothelial cell activation and release of EMPs expressing inducible cell adhesion molecules. It is proposed that this mechanism could account in part for the vascular injury associated with superantigen-mediated diseases including Kawasaki disease.
研究内皮细胞作为T细胞超抗原呈递细胞的可能性,以及这种相互作用导致内皮细胞活化和损伤的可能性。
将II类主要组织相容性复合体(MHC)阳性的人脐静脉内皮细胞(HUVECs)与纯化的T细胞以及超抗原葡萄球菌肠毒素B(SEB)或中毒性休克综合征毒素1(TSST-1)共培养4小时。用荧光偶联单克隆抗体染色后,对HUVECs和T细胞进行流式细胞术分析,以检测Vβ限制性T细胞对内皮细胞单层的黏附、Vβ限制性T细胞活化(CD69上调)、内皮细胞活化标志物表面表达以及内皮微粒(EMPs)的产生。
纯化的T细胞与II类MHC阳性HUVECs以及TSST-1或SEB共培养导致CD4和CD8细胞Vβ限制性CD69上调(TSST-1激活Vβ2;SEB激活Vβ3、Vβ5.1和Vβ12)。此外,4小时时存在CD4和CD8 T细胞Vβ限制性对HUVEC单层的黏附。在T细胞存在的情况下,暴露于超抗原后,II类MHC阳性HUVECs上细胞间黏附分子1、E选择素和血管细胞黏附分子1的表达上调,并且活化的HUVECs释放的EMPs增加,其发生时间早且幅度大于肿瘤坏死因子α刺激所观察到的情况。
II类MHC阳性内皮细胞在体外作为CD4和CD8淋巴细胞的有效超抗原呈递细胞发挥作用。内皮细胞与T细胞之间的双重信号传导导致Vβ限制性活化和对内皮单层的黏附以及内皮细胞活化和表达诱导性细胞黏附分子的EMPs释放。提出该机制可能部分解释与包括川崎病在内的超抗原介导疾病相关的血管损伤。